Revolution Medicines, Inc. (RVMDW) Capital expenditures 2018–2025
Revolution Medicines, Inc. (RVMDW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$16.0MFY2025 · since FY2018: $1.5M → $16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.0M | +55.1% |
| FY2024 | $10.3M | +33.4% |
| FY2023 | $7.7M | -28.5% |
| FY2022 | $10.8M | +65.7% |
| FY2021 | $6.5M | +122.6% |
| FY2020 | $2.9M | +13.3% |
| FY2019 | $2.6M | +72.7% |
| FY2018 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Operating cash flowRVMDW Free cash flowRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →